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Abstract Human tear lipocalin (TL) is an unusual member of
the lipocalin protein family, since it is known to bind a large
variety of lipophilic ligands in vivo and acts as a cysteine
proteinase inhibitor in vitro. It is suggested to function as a
physiological protection factor by scavenging lipophilic poten-
tially harmful compounds. Since protein-protein interaction or
macromolecular complexation is a common feature of many
lipocalins, we applied phage display technology to identify TL
interacting proteins. By panning of a human prostate cDNA
phagemid library against purified TL we isolated a thioredoxin
(Trx) encoding phage clone. Biochemical analysis revealed that
TL indeed interacts with Trx and is reduced by this redox
protein. Reduction of the TL-specific disulfide bond is of
functional relevance, since the reduced protein shows a nine-fold
increase in ligand affinity when tested with retinoic acid as
ligand.
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1. Introduction
The protein superfamily of lipocalins consists of small
mainly secretory proteins de¢ned on the basis of conserved
amino acid sequence motifs and their common structure.
Functionally they share several properties including the ability
to bind a remarkable array of small hydrophobic molecules,
binding to speci¢c receptors and the formation of macromo-
lecular complexes (reviewed in [1]). However, whereas numer-
ous lipophilic ligands which can bind to lipocalins have been
identi¢ed, only limited data are available concerning potential
interacting protein partners.
Human tear lipocalin (TL, identical with von Ebner’s gland
protein) is an unusual lipocalin member since it is known to
bind a large number of relatively insoluble lipids with binding
properties that di¡er from those of other family members [2,3]
and in addition it acts as a cysteine proteinase inhibitor at
least in vitro [4]. TL has been found to be expressed in tear
glands [5,6], sublingual glands [7], prostate [8], mucosal glands
of the tracheobronchial tree [9] and in the human nasal mu-
cosa [10]. Although not all of the biological properties of TL
have been determined so far, there is clear evidence that this
protein acts as a physiological protection factor of epithelia,
probably by scavenging harmful lipophilic molecules, and/or
might play a role in the control of in£ammatory processes by
its protease inhibition [4,9]. Both of these functions would
require interaction with other proteins.
One of the most powerful methods to isolate and identify
interacting cytoplasmic or secreted proteins is phage display
technology [11]. This technique was shown to be, beside its
numerous applications in antibody technology [12], especially
useful in identi¢cation of protease-substrate complexes or in
protein-receptor interaction [13,14].
Therefore we investigated the applicability of a phage dis-
play shotgun cloning strategy to identify proteins that poten-
tially interact with TL. Here we describe an interaction of TL
with the redox mediator human thioredoxin (Trx). This inter-
action seems to be of physiological relevance for lipophilic
ligand binding of TL, since disul¢de bond reduction markedly
in£uences the substrate a⁄nity of TL.
2. Materials and methods
2.1. Materials
A polyclonal antiserum against phage protein pVIII was purchased
from Clontech (USA) and secondary antibodies were from Sigma
(Germany). Human Trx and bovine thioredoxin reductase (TR)
were purchased from IMCO Corp. (Sweden). Reduced Trx was pre-
pared according to [15]. Human TL was prepared as described [5] and
was routinely delipidated by chloroform/methanol extraction [2]. An
enzymatically reduced TL was prepared using the human Trx system
as described [16]. Reaction was performed in TE at room temperature
for 4 h. Protein aliquots were treated with one volume of 10.8 mM
iodoacetamide (Sigma, USA) dissolved in nitrogen-saturated 0.2 M
Tris-HCl, pH 8.0, per three volumes of reaction mixture. For chemical
reduction protein aliquots were treated with 100 mM 2-mercaptoetha-
nol (2-ME) and iodoacetamide (¢nal concentration 97 WM). The re-
action mixtures were puri¢ed by ion exchange chromatography as
described [5].
2.2. RNA isolation, reverse transcription and construction of a human
prostate cDNA library in phagemid pEZM3
Total RNA from human prostate was extracted by RNazol B (Cin-
na/Biotecx) which is based on the method developed by Chomczynski
and Sacchi [17]. Poly(A) RNA was prepared using Dynabeads
Oligo(dT)25 (Dynal, Norway) exactly as described by the supplier.
A portion of prostate mRNA was reverse transcribed using random
primers and Superscript II reverse transcriptase (Gibco BRL, UK),
according to the manufacturer’s speci¢cations. The cDNA was blunt
ended with Klenow fragment, subjected to agarose gel electrophoresis
and the region between 3000 and 200 base pairs was electroeluted and
cloned into the EcoRV site of phagemid pEZM3 (Clontech, USA).
Another portion of the prostate mRNA was reverse transcribed using
oligo(dT)-BglII primers or oligo(dT)-ApaI primers and then ligating
the dsDNA to an adapter containing a SalI site. After digestion with
an excess amount of the appropriate restriction enzyme (50^100 U/Wg
DNA) the cDNA was size selected by agarose gel electrophoresis and
directionally cloned into the SalI and BglII or ApaI sites of phagemid
pEZM3 (Clontech, USA).
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2.3. Phage production and panning procedure
Phagemids from both batches were mixed and transformed into the
amber suppressor Escherichia coli strain TG1 by electroporation and
grown in 2UYT/glucose medium. Cultures were grown to mid-log
phase and infected with M13K07 helper phage (5U1010 plaque-form-
ing units/ml) and grown for an additional 2 h. After centrifugation the
supernatant was discarded to remove glucose. The pellet was resus-
pended in 2UYT supplemented with ampicillin (50 Wg/ml) and kana-
mycin (50 Wg/ml) and the culture was grown overnight. Phages were
isolated by polyethylene glycol 8000. Enrichment of phages was per-
formed in microtiter plates (MaxiSorp, Nunc, Denmark) under the
following conditions: wells were precoated with 2 Wg puri¢ed TL for
2 h at room temperature, washed and blocked with 1% bovine serum
albumin (BSA). Wells were incubated (1 h, 37‡C) with 50 Wl of mixed
phages (1010^1011 colony-forming units). Following incubation the
wells were washed twice (¢rst round of panning), ¢ve times (second
to ¢fth round of panning) with TBS, 0.05% Tween-20. Trapped
phages were rescued by addition of 0.1 ml of log-phase TG1 cells
and incubation for 30 min at 37‡C. The enriched TG1 library was
plated out on 2UYT/amp/glucose/MgCl2 plates for titer determina-
tion and estimation of recovery of trapped phages.
2.4. Con¢rmation of TL-Trx interaction by ELISA
Wells were precoated with human Trx (1 Wg/well) and incubated
with puri¢ed TL (0.5^2 Wg/well) at 4‡C for 12 h. After blocking (PBS
with 0.2% gelatin, 0.1% Tween 20) and washing, the wells were in-
cubated with anti-TL antiserum for 2 h at room temperature. After
removing primary antibody and washing, the wells were incubated
with horseradish peroxidase-conjugated secondary antibody for 2 h.
Afterwards 50 Wl of substrate solution (containing H2O2 and 3,3P,5,5P-
tetramethylbenzidine) was added and incubated for 30 min. The re-
action was stopped by adding 10 Wl of 1 N H2SO4 and the A405 was
determined. BSA-coated wells were used as a blank. The Trx-pre-
coated wells without TL showed the same background as the blank.
2.5. Trx reduction assay and gel electrophoresis
The reduction of TL by the Trx/TR system was assayed spectro-
photometrically essentially as described previously [15,16] in a Milton-
Roy Spectronic 3000 spectrophotometer by monitoring the oxidation
of NADPH at 340 nm using 1 cm semi-microcuvettes. A change in
A340 of 0.0062 between the reaction and reference cuvettes represents
the reduction of 1 WM disul¢de. Gel electrophoresis under non-reduc-
ing and reducing conditions was performed using 14% polyacrylamide
Tris-glycine gels (Novex, USA) without or with addition of 2-ME.
2.6. Ligand binding studies by £uorescence quenching experiments
For binding studies an assay which is based on the decrease in
tryptophan £uorescence after ligand binding according to [18] was
used. Fluorescence measurements were made with a Hitachi F4500
£uorescence spectrophotometer using 5 nm band width at a constant
temperature (22‡C). Excitation was at 295 nm and emission was re-
corded between 330 and 350 nm. For each measurement 200 Wl pro-
tein solution (40 nM^1 WM) in 10 mM sodium phosphate, 100 mM
NaCl (pH 7.3) was mixed with 2 Wl of appropriately diluted retinoic
acid solution. The mixtures were stirred for 5 min at room temper-
ature and the tryptophan £uorescence was measured in three inde-
pendent experiments. A stock solution of all-trans retinoic acid (Sig-
ma, USA) was gravimetrically prepared in DMF and further diluted
in DMF as required.
3. Results
3.1. Characterization of the human prostate cDNA phagemid
library and panning against TL
TL was found to be expressed in a variety of human glands
or tissues [5^10]. For experimental reasons we decided to use
human prostate as a source of mRNA for constructing a
phagemid cDNA library. As cloning vector we used a gene
pIII fusion-based phagemid system, since it is known that
relatively large fusion moieties can be added onto pIII without
resulting in steric interference with protein-ligand interaction
[19]. To maximize the complexity of the phagemid cDNA
library two di¡erent cDNA synthesis strategies were per-
formed as described above. Each ¢nal library consisted of
more than 3U106 individual clones. Before panning both li-
braries were pooled. Analysis of the insert size of the pooled
phagemids showed that although we used a size-selected
cDNA some of the phages contained inserts smaller than
200 bp.
Fig. 1. Nucleotide sequence and deduced amino acid sequence of the phagemid insert encoding human Trx. Following the gene III leader se-
quence the multiple cloning site is indicated. The EcoRV half sites enclosing the insert are marked by arrows. The ¢rst six amino acids of the
insert (in italics) are encoded by the 5P-untranslated region of the Trx mRNA.
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3.2. Nucleotide sequence analysis of a⁄nity-selected phage
clones
After ¢ve rounds of panning against puri¢ed TL as a bait,
the enriched phagemid library was screened for interacting
clones by ELISA using an anti-pVIII polyclonal antibody
and horseradish peroxidase as secondary antibody. From 88
clones used per ELISA plate about 15% reacted with the anti-
pVIII antibody. Positive reacting phagemid clones were sub-
jected to further analysis. We selected 10 positive phages, six
of them harbored a 330 bp insert. Sequence analysis showed
that these inserts encode human Trx (Fig. 1). All of the six
phages contained the same insert. The Trx insert starts at the
gene III leader sequence-insert fusion with CAG encoding an
in frame Gln which is located six amino acids upstream of the
original Trx-speci¢c start Met and stops with GAA encoding
a Glu. In the original Trx sequence this Glu is located in front
of the last two C-terminal amino acids [20].
It should be mentioned that a set of other positive phages
contained an insert which showed signi¢cant homology (75%
and 65% identity) with uncharacterized genes from Mus mus-
culus and Fugu rubripes. This insert is currently under further
investigation.
3.3. Con¢rmation of TL-Trx interaction by ELISA and
enzymatic analysis
To con¢rm the TL-Trx interaction revealed by phage dis-
play, in the next step we performed a sandwich ELISA assay
using microtiter wells coated with puri¢ed human Trx and
incubated with di¡erent amounts of puri¢ed human TL.
Bound TL was detected with an anti-TL-speci¢c antibody
[5]. A linear increase of A405 values up to 0.26 (corrected by
subtraction of the BSA-coated blank) was found with increas-
ing amounts of TL added, thus indicating signi¢cant binding
of TL to Trx and con¢rmation of the results from phage dis-
play.
Enzymatic cleavage of disul¢de bonds by Trx can be fol-
lowed by a Trx/TR-coupled spectrophotometric assay [15].
Since it is known that TL has one characteristic disul¢de
bond formed by Cys79 and Cys171, we used this assay to test
whether TL serves as a substrate for Trx (Fig. 2). The signi¢-
cant NADPH consumption and a time-dependent kinetics
show that the disul¢de bond of TL is indeed cleaved by the
Trx system.
In addition, the enzymatic reduction of TL can also be
followed by SDS-PAGE, since the oxidized TL has a more
enhanced electrophoretic mobility than the fully reduced form
when analyzed without 2-ME treatment (Fig. 3).
3.4. In£uence of disul¢de reduction on lipophilic ligand binding
of TL
Recently, it was demonstrated that the disul¢de bridge in
TL is important for conferring protein rigidity and there was
some evidence that it might in£uence ligand a⁄nity [21]. Since
the latter ¢nding would be of physiological relevance, we in-
vestigated the retinoic acid binding activities of a TL reduced
by the Trx system compared to a TL which was chemically
reduced and an oxidized TL. These investigations were done
using £uorescence titration analysis by taking advantage of
the intrinsic £uorescence of the conserved Trp in TL. It is
known for several lipocalins that binding of lipophilic ligands
results in a drastic decrease of the intrinsic protein £uores-
cence due to energy transfer from excited Trp [18]. We found
that retinoic acid possesses essentially the same a⁄nity for TL
as retinol [5], therefore retinoic acid was used as a ligand,
since it is more soluble in water and chemically more stable
than retinol. Fig. 4 shows the £uorescence data from these
experiments. Addition of increasing amounts of retinoic acid
resulted in a decrease of £uorescence in both oxidized and
reduced TL. However, the decrease obtained with reduced
TL was sharper than with oxidized TL. The binding constant
derived from mathematical analysis was calculated to be
0.96 WM for the oxidized protein and 0.11 WM for the reduced
Fig. 2. Disul¢de reduction of TL by the human Trx system. The re-
actions were performed in TE bu¡er containing 400 WM NADPH.
TL was added to both reaction and reference cuvettes, to a ¢nal
concentration of 10 WM. Human Trx and bovine TR were added to
a ¢nal concentration of 3 WM to the reaction cuvette. Reference
cuvettes contained either Trx (3 WM) or TR (3 WM). Reaction and
reference cuvettes were measured simultaneously in an 8-position
cell holder and the background was subtracted automatically.
Fig. 3. SDS-PAGE of human TL following incubation with the hu-
man Trx system and subsequent alkylation. Lane 1: fully 2-ME-re-
duced TL; lane 2: molecular weight standards; lanes 3^7: TL
treated with Trx system for 15 s (lane 3), 5 min (lane 4), 10 min
(lane 5), 15 min (lane 6) and 1 h (lane 7) followed by alkylation
with iodoacetamide. Samples in lanes 3^7 were treated with SDS
bu¡er without 2-ME prior to electrophoresis.
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protein. Thus the reduced protein has a nine-fold higher af-
¢nity for the ligand. There was no signi¢cant di¡erence be-
tween an TL enzymatically reduced by the Trx system or a
chemically reduced protein (Fig. 4).
4. Discussion
In the present study we demonstrated that human TL
physically interacts with Trx and found that this interaction
signi¢cantly in£uenced the ligand binding properties of TL.
Since all Trx proteins can serve as general physiological pro-
tein disul¢de oxidoreductases that in combination with
NADPH and Trx reductase are able to catalyze protein re-
duction [22], our data strongly suggest that this activity is of
relevance for lipocalins in vivo. Almost all of the lipocalin
members investigated so far are presumed to have at least
one intramolecular disul¢de bond. In nearly all of them there
is a conserved disul¢de bond involving the carboxy-terminal
end, indicating functional importance of this structural fea-
ture. Although there have been few investigations on the sig-
ni¢cance of these intracellular disul¢de bonds in general, it
was clearly demonstrated recently [21] that reduction of the
disul¢de bond in TL has no in£uence on the predominant L-
sheet structure of the protein but is important in conferring
protein rigidity. In addition, when comparing CD spectra
from oxidized and chemically reduced protein which was in-
cubated with retinol, enhanced optical activity was generated
by bound retinol with the reduced protein, which was inter-
preted as a more avid ligand binding in the reduced state [21].
Our £uorescence titration experiments with retinoic acid as
ligand clearly support this interpretation. The reduced protein
showed a nine-fold increase in a⁄nity to retinoic acid com-
pared to the oxidized form. Since Trx is a physiological redox
protein our studies strongly suggest that reduction of TL by
this system might be of relevance in vivo.
There is increasing evidence that human TL is involved in
tissue protection during in£ammation and infection [4,9]. On
the other hand, it is well known that expression of Trx is
inducible by in£ammatory cytokines and elevated levels of
Trx have been found in chronic infection and in£ammation
[23,24]. Moreover, activated lymphocytes secrete Trx [25], po-
tentially elevating local concentrations. Higher rates of reduc-
tion could also be expected under less aerobic conditions, a
situation which is likely to be found in bacterial infections.
One might therefore speculate that modi¢cation of TL by Trx
resulting in enhanced ligand a⁄nity could be a very fast and
e⁄cient mechanism to increase the protective potential of this
lipid scavenger at very local areas.
The modulation of ligand binding a⁄nity by disul¢de bond
reduction may have implications for the entire lipocalin fam-
ily. Therefore a Trx-based reduction mechanism could be of
relevance also for other lipocalin members. Indeed, a ¢rst
preliminary experiment indicated that apoD, another lipocalin
member, can also be enzymatically reduced by the Trx system
(data not shown). However, more extensive investigations will
be necessary to prove the functional consequence of this re-
action and to see whether this mechanism is of general rele-
vance for the lipocalins.
Finally, our results demonstrate that a phage display shot-
gun cloning strategy using complex cDNA libraries is a reli-
able method to ¢nd novel protein interactions with lipocalins.
This approach might also be useful for isolation and charac-
terization of lipocalin receptors, since with conventional bio-
chemical methods only limited results have been obtained so
far.
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Fig. 4. Determination of the ligand a⁄nity for retinoic acid of oxidized and reduced TL by £uorescence titration experiments. Puri¢ed samples
of oxidized (R), enzymatically (F) or chemically (b) reduced TL were each applied at a concentration of 1 WM and mixed with increasing
amounts of retinoic acid. Ligand concentration was plotted against the relative decrease in £uorescence. The set of data points was analyzed by
standard mathematical methods and a curve was ¢tted using non-linear hyperbolic regression. The association constant for retinoic acid as cal-
culated was 0.96 WM for the oxidized protein and 0.11 WM for the reduced protein.
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